COMMUNIQUÉS West-GlobeNewswire

Shire plc : Rule 2.9 Announcement
18/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 18 May 2018 Shire [...]
Curetis Publishes Business and Financial Update for the First Quarter 2018
18/05/2018
Curetis Publishes Business and Financial Update for the First Quarter 2018 - Received U.S. FDA clearance for Unyvero System and LRT Cartridge - Grew revenues in EMEA direct selling markets by 518% vs Q1 2017 - Closed [...]
Adverum Biotechnologies Presents Additional Long-term Preclinical Data on ADVM-022 in Wet AMD at ASGCT 21st Annual Meeting
18/05/2018
-- Single Intravitreal Administration of Gene Therapy ADVM-022 Provides Long-term Protection in Nonhuman Primate Model of Wet AMD -- MENLO PARK, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. ( [...]
MBI Distributing, Inc. Issues Voluntary Nationwide Recall of homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir due to a lack of process controls
18/05/2018
LINDON, Utah, May 17, 2018 (GLOBE NEWSWIRE) -- MBI Distributing, Inc. is voluntarily recalling all lots of homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver- [...]
Novartis and Amgen announce FDA approval of Aimovig(TM) (erenumab), a novel treatment developed specifically for migraine prevention
18/05/2018
Migraine is a severe neurologic disease that profoundly impacts millions of patients in the United States Aimovig is the first and only FDA-approved treatment to block the calcitonin gene-related peptide receptor (CGRP- [...]
Voyager Therapeutics Announces New Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting
18/05/2018
VY-SOD101 achieves meaningful suppression of disease-causing gene of ALS in large mammals after a one-time administration Results during the second half of 2018 from further delivery optimization efforts with VY-SOD101 [...]
Kane Biotech Announces First Quarter 2018 Financial Results, Granting of Options and Investor Relations Improvements
17/05/2018
WINNIPEG, Manitoba, May 17, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF) (the “Corporation” or “Kane Biotech”) announces its First Quarter 2018 Financial Results, granting of options and [...]
VA, Cerner Announce Agreement to Provide Seamless Care for Veterans
17/05/2018
WASHINGTON, May 17, 2018 (GLOBE NEWSWIRE) -- Today the Department of Veterans Affairs (VA) announced an agreement with Cerner Government Services, Inc., a wholly owned subsidiary of Cerner Corporation, a global leader [...]
Celiac Disease KOL and Management Meetings around the Digestive Disease Week (DDW) conference on Monday, June 4, 2018, in Washington, D.C.
17/05/2018
RALEIGH, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT ), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory [...]
ELSALYS BIOTECH lance son introduction en Bourse sur le marché Euronext Growth® Paris
17/05/2018
Offre au public d'un montant brut de 15 M€ [a] pouvant être porté à environ 19,8 M€ en cas d'exercice intégral de la clause d'extension et de l'option de surallocation (l' « Offre ») Fourchette indicative de prix : [...]
ToolGen, Inc., Demonstrates CRISPR/cas9 Gene Editing Improves Anti-Tumor Activity of Human CAR-T Cells
17/05/2018
Knockout of T-Cell suppression pathway improves T-cell anti-tumor activity in a mouse glioblastoma model Data Presented at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting SEOUL, South Korea, May [...]
CorVel Announces Fiscal Earnings Release Webcast
17/05/2018
IRVINE, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- In conjunction with CorVel Corporation’s (NASDAQ: CRVL ) fiscal year earnings release, CorVel will stream a webcast over the Internet on Thursday, May 31st at 11:30 am [...]
Nohla Announces EHA Abstract Acceptance on Dilanubicel (NLA101) Off-the-Shelf Cell Therapy Showing Excellent Long-term Survival Outcomes
17/05/2018
86% Disease-Free and Overall Survival Rates in Dilanubicel Patients Five Years After Cord Blood Transplantation SEATTLE, May 17, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off-the- [...]
Reducing Health Care Provider Stress and Burnout to Improve Satisfaction and Patient Care
17/05/2018
New Articles in May 2018 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., May 17, 2018 (GLOBE NEWSWIRE) -- Reducing health care provider stress and burnout to improve [...]
La Jolla Pharmaceutical Company Announces LJPC-401 Presentations at 23rd Congress of the European Hematology Association
17/05/2018
SAN DIEGO, May 17, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
Medifirst Solutions Launches Specialty Prescription Billing and Pharmacy Solutions Division
17/05/2018
FREEHOLD, NJ, May 17, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]
OSE Immunotherapeutics to Present at 4th Annual Immuno-Oncology: BD&L and Investment Forum
17/05/2018
Forum to be held in Chicago, IL, on June 1, 2018 NANTES, France, May 17, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE) today announces that Alexis Peyroles, chief executive officer, [...]
Aptose to Present New CG’806 Data at the 23rd Congress of the European Hematology Association
17/05/2018
SAN DIEGO and TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics targeting [...]
GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at 23rd European Hematology Association (EHA) Congress
17/05/2018
SOUTH SAN FRANCISCO, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that data supporting its voxelotor program in sickle cell disease (SCD) will be [...]

Pages